PKI-166
PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer.
Product Specifications
CAS Number
187724-61-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
330.38
Molecular Formula
C20H18N4O
Notes
Research use only, not for human use.
Receptor
VEGFR
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog